ID21256A - Garam bismuth dari antibiotik gugus moenomycin, proses untuk pembuatannya, pemakaiannya dan sediaan farmasi yang terdiri atas garam tersebut - Google Patents

Garam bismuth dari antibiotik gugus moenomycin, proses untuk pembuatannya, pemakaiannya dan sediaan farmasi yang terdiri atas garam tersebut

Info

Publication number
ID21256A
ID21256A IDP980326A ID980326A ID21256A ID 21256 A ID21256 A ID 21256A ID P980326 A IDP980326 A ID P980326A ID 980326 A ID980326 A ID 980326A ID 21256 A ID21256 A ID 21256A
Authority
ID
Indonesia
Prior art keywords
salt
clusters
usage
manufacture
processes
Prior art date
Application number
IDP980326A
Other languages
English (en)
Indonesian (id)
Inventor
Laszlo Vertesy
Michael Kurz
Astrid Markus
Gerhard Prof Dr Seibert
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ID21256A publication Critical patent/ID21256A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IDP980326A 1997-03-11 1998-03-05 Garam bismuth dari antibiotik gugus moenomycin, proses untuk pembuatannya, pemakaiannya dan sediaan farmasi yang terdiri atas garam tersebut ID21256A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19709897A DE19709897A1 (de) 1997-03-11 1997-03-11 Wismutsalze von Antibiotika der Moenomycin-Gruppe, Verfahren zu ihrer Herstellung, ihre Verwendung und solche Salze enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
ID21256A true ID21256A (id) 1999-05-12

Family

ID=7822914

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP980326A ID21256A (id) 1997-03-11 1998-03-05 Garam bismuth dari antibiotik gugus moenomycin, proses untuk pembuatannya, pemakaiannya dan sediaan farmasi yang terdiri atas garam tersebut

Country Status (20)

Country Link
US (1) US6077830A (cs)
EP (1) EP0864579B1 (cs)
JP (1) JPH1192489A (cs)
KR (1) KR19980080102A (cs)
CN (1) CN1194984A (cs)
AR (1) AR011457A1 (cs)
AT (1) ATE242256T1 (cs)
AU (1) AU734748B2 (cs)
BR (1) BR9800861A (cs)
CA (1) CA2231365A1 (cs)
CZ (1) CZ71298A3 (cs)
DE (2) DE19709897A1 (cs)
DK (1) DK0864579T3 (cs)
ES (1) ES2201351T3 (cs)
HU (1) HUP9800512A3 (cs)
ID (1) ID21256A (cs)
PL (1) PL325263A1 (cs)
PT (1) PT864579E (cs)
RU (1) RU2204565C2 (cs)
TR (1) TR199800421A3 (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141244B1 (en) * 1992-03-02 2006-11-28 Chiron Srl Helicobacter pylori proteins useful for vaccines and diagnostics
JPH10502366A (ja) * 1994-07-01 1998-03-03 リカン・リミテッド ヘリコバクター・ピロリ抗原タンパク質調製品およびイムノアッセイ
GB2324093A (en) * 1996-01-04 1998-10-14 Rican Limited Helicobacter pylori bacterioferritin
SE0101379D0 (sv) * 2001-04-18 2001-04-18 Diabact Ab Komposition som hämmar utsöndring av magsyra
WO2003018054A1 (en) * 2001-08-31 2003-03-06 Chiron Srl. Helicobacter pylori vaccination
KR100594353B1 (ko) * 2002-05-28 2006-07-03 주식회사 엠디바이오알파 신규한 인삼잎 및 줄기 다당체, 그 제조방법 및 그를활성성분으로 함유하는 항암제 및 항암보조제 조성물
SE0203065D0 (sv) * 2002-10-16 2002-10-16 Diabact Ab Gastric acid secretion inhibiting composition
RU2265437C2 (ru) * 2003-07-02 2005-12-10 Суханов Александр Владимирович Способ лечения заболеваний желудка и двенадцатиперстной кишки, вызванных helicobacter pylori
US9115358B2 (en) 2006-08-11 2015-08-25 President And Fellows Of Harvard College Moenomycin biosynthesis-related compositions and methods of use thereof
EP2205074A4 (en) * 2007-10-04 2013-07-31 Harvard College MOENOMYCIN ANALOGUE, SYNTHESIS PROCESS AND USE
US9902985B2 (en) 2012-04-06 2018-02-27 President And Fellows Of Harvard College Chemoenzymatic methods for synthesizing moenomycin analogs
US9273084B2 (en) 2012-04-06 2016-03-01 President And Fellows Of Harvard College Moenomycin analogs, methods of synthesis, and uses thereof
EP2850091A1 (en) 2012-04-06 2015-03-25 President and Fellows of Harvard College Methods and compounds for identifying glycosyltransferase inhibitors
US12060148B2 (en) 2022-08-16 2024-08-13 Honeywell International Inc. Ground resonance detection and warning system and method

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU170987B (hu) * 1974-07-23 1977-10-28 Hoechst Ag Sposob poluchenija menomicina
DE3887353T2 (de) * 1987-10-12 1994-05-05 Capability Services Pty Ltd Behandlungsverfahren für magen-darm-krankheiten.
US5315038A (en) * 1988-08-20 1994-05-24 Hoechst Aktiengesellschaft Microorganism for breaking down moenomycins, a process for the breakdown, and the use of the breakdown products
ATE134641T1 (de) * 1988-08-20 1996-03-15 Hoechst Ag Neuer mikroorganismus zum abbau von moenomycinen, verfahren zum abbau sowie die verwendung der abbauprodukte
US5506140A (en) * 1988-08-20 1996-04-09 Hoechst Aktiengesellschaft Bacillus strain for breaking down moenomycins
US5260206A (en) * 1988-08-20 1993-11-09 Hoechst Aktiengesellschaft Enzymes for breaking down moenomycins
US5206405A (en) * 1988-08-20 1993-04-27 Hoechst Aktiengesellschaft 2-alkenyloxy-3-(phosphono)oxypropanoic acids derived from the cleavage of phosphoglycolipid antibiotics
GB9115190D0 (en) * 1991-07-12 1991-08-28 Rhone Poulenc Rorer Ltd New compositions of matter
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
RU2013448C1 (ru) * 1992-03-23 1994-05-30 Всесоюзный научно-исследовательский институт генетики и селекции промышленных микроорганизмов Штамм streptomyces bambergiensis - продуцент моеномицина а
EP0652205A3 (de) * 1993-11-04 1995-08-30 Hoechst Ag Moenomycin-Abbauprodukte mit hydroxylierter oder oxidierter Lipidseitenkette und Moenomycin-Analoga, ein Verfahren zur Herstellung und die Verwendung dieser Verbindungen.
DE4340774A1 (de) * 1993-11-30 1995-06-01 Hoechst Ag Moenomycin und dessen Derivate zur Herstellung von Arzneimitteln, sowie Arzneimittel mit einem Gehalt an Moenomycin oder dessen Derivaten

Also Published As

Publication number Publication date
TR199800421A2 (xx) 1998-09-21
HUP9800512A3 (en) 1998-12-28
DE19709897A1 (de) 1998-09-17
ES2201351T3 (es) 2004-03-16
DE59808559D1 (de) 2003-07-10
AU5834498A (en) 1998-09-17
HUP9800512A2 (hu) 1998-10-28
HU9800512D0 (en) 1998-04-28
EP0864579B1 (de) 2003-06-04
AU734748B2 (en) 2001-06-21
BR9800861A (pt) 1999-12-07
CZ71298A3 (cs) 1998-09-16
KR19980080102A (ko) 1998-11-25
TR199800421A3 (tr) 1998-09-21
PT864579E (pt) 2003-10-31
US6077830A (en) 2000-06-20
AR011457A1 (es) 2000-08-16
DK0864579T3 (da) 2003-09-22
CN1194984A (zh) 1998-10-07
CA2231365A1 (en) 1998-09-11
JPH1192489A (ja) 1999-04-06
RU2204565C2 (ru) 2003-05-20
PL325263A1 (en) 1998-09-14
ATE242256T1 (de) 2003-06-15
EP0864579A3 (de) 2000-06-21
EP0864579A2 (de) 1998-09-16

Similar Documents

Publication Publication Date Title
ID21256A (id) Garam bismuth dari antibiotik gugus moenomycin, proses untuk pembuatannya, pemakaiannya dan sediaan farmasi yang terdiri atas garam tersebut
ID20717A (id) Proses yang diperbaiki untuk memperoleh prekursor-prekursor insulin yang mempunyai jembatan-jembatan sistin yang terikat dengan tepat
ID24929A (id) Turunan 2-aril-8-oksodihidropurin, proses pembuatannya, komposisi farmasinya yang mengandungnya, dan senyawa antaranya
ID21045A (id) Asam amino termodifikasi, obat-obatan yang mengandung senyawa ini dan proses pembuatannya
ID21393A (id) Asam benzazepinon-n-asetat tersubstitusi-asam fosfonat, proses pembuatan dan obat-obat yang mengandung senyawa ini
ID20984A (id) Sistim multikomponen untuk memodifikasi, menguraikan atau mengelantang lignin atau bahan-bahan yang mengandung-lingin, serta proses untuk pembuatannya
AU5429399A (en) Fluorescent assay for biological systems
FR2764989B1 (fr) Procede de dosage du c-peptide
ID20137A (id) Turunan propanolamina, proses pembuatannya, sediaan farmasi yang mengandung senyawa ini, dan penggunannya
ID22233A (id) Tablet telan yang terdiri dari parasetamol
ZA964818B (en) Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the NHE-inhibitory efficacy of compounds.
ID24596A (id) Mikrosfer-mikrosfer farmasi yang mengandung asam valproat untuk pemakaian oral
AU8591898A (en) Pharmaceutical compounds
AU9365498A (en) Photocatalysts for the degradation of organic pollutants
AU8636798A (en) Pharmaceutical compounds isolated from aristolochia taliscana
DK1032370T3 (da) Porøse hydroxyapatitpartikler som bærere for lægemiddelstoffer
IL134458A0 (en) Drug discovery using multiple membrane mimetic affinities
HUP0104994A3 (en) Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds, process for their preparation and medicaments containing them
AU3057299A (en) Sustained-release composition containing cefaclor
AU4548999A (en) Chemical delivery system having purge system utilizing multiple purge techniques
ID27023A (id) Turunan imidazola bersubstitusi bifenilsulfonil, proses penyiapannya, penggunaannya sebagai obat atau zat diagnosa dan obat yang mengandungnya
ID17038A (id) Orto-benzoilguanidin tersubstitusi, proses untuk pembuatannya, pemakaiannya sebagai obat atau diagnostik, dan obat yang mengandungnya
GB9506844D0 (en) Pharmaceutical microencapsulation
GB0010818D0 (en) PC based systems for driving of multiple screens
AU6480299A (en) Pharmaceutical compounds